Indian Journal of Nuclear Medicine

CASE REPORT
Year
: 2013  |  Volume : 28  |  Issue : 2  |  Page : 108--111

Somatostatin receptor positron emission tomography/computed tomography (PET/CT) in the evaluation of opsoclonus-myoclonus ataxia syndrome


Prathamesh Joshi, Vikram Lele 
 Department of Nuclear Medicine and PET-CT, Jaslok Hospital & Research Centre, Worli, Mumbai, Maharashtra, India

Correspondence Address:
Prathamesh Joshi
Department of Nuclear Medicine and PET-CT, Jaslok Hospital and Research Centre, Worli, Mumbai, Maharashtra
India

Opsoclonus-myoclonus ataxia (OMA) syndrome is the most common paraneoplastic neurological syndrome of childhood, associated with occult neuroblastoma in 20%-50% of all cases. OMA is the initial presentation of neuroblastoma in 1%-3% of children. Conventional radiological imaging approaches include chest radiography and abdominal computed tomography (CT). Nuclear medicine techniques, in form of 123 I/ 131 I-metaiodobenzylguanidine (MIBG) scintigraphy have been incorporated in various diagnostic algorithms for evaluation of OMA. We describe use of somatostatin receptor PET/CT with 68 Gallium- DOTA-DPhe 1 , Tyr 3 -octreotate (DOTATATE) in diagnosis of neuroblastoma in two cases of OMA.


How to cite this article:
Joshi P, Lele V. Somatostatin receptor positron emission tomography/computed tomography (PET/CT) in the evaluation of opsoclonus-myoclonus ataxia syndrome.Indian J Nucl Med 2013;28:108-111


How to cite this URL:
Joshi P, Lele V. Somatostatin receptor positron emission tomography/computed tomography (PET/CT) in the evaluation of opsoclonus-myoclonus ataxia syndrome. Indian J Nucl Med [serial online] 2013 [cited 2020 Apr 4 ];28:108-111
Available from: http://www.ijnm.in/article.asp?issn=0972-3919;year=2013;volume=28;issue=2;spage=108;epage=111;aulast=Joshi;type=0